drugset / Trial / NCT01974739

Hydrochloorthiazide and Hypernatriaemie

NCT01974739 ↗

Completed 50 enrolled Frisius Medisch Centrum
RandomizedSingle-groupQuadruple-blindTreatment

Summary

Acquired hypernatremia appears to be associated with mortallity in ICU. To reduce hypernatremia and shorten the time of hypernatremia, we investigate the effect of hydrochloorthiazide compared to a placebo

Timeline

Start
2013-09
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrochloorthiazide Unknown 25 mg —

Indications

No indication recorded.